Microbix Biosystems (TSE:MBX) Hits New 52-Week High – Here’s What Happened

Microbix Biosystems Inc. (TSE:MBX)’s share price reached a new 52-week high on Wednesday . The stock traded as high as C$0.50 and last traded at C$0.50, with a volume of 1457199 shares traded. The stock had previously closed at C$0.44.

Microbix Biosystems Stock Down 2.0 %

The company has a current ratio of 6.62, a quick ratio of 5.57 and a debt-to-equity ratio of 22.68. The firm has a market capitalization of C$66.98 million, a P/E ratio of 12.25 and a beta of 0.34. The stock’s 50-day simple moving average is C$0.38 and its 200-day simple moving average is C$0.35.

Insider Transactions at Microbix Biosystems

In related news, Director Cameron Lionel Groome sold 200,000 shares of the stock in a transaction that occurred on Wednesday, January 22nd. The stock was sold at an average price of C$0.43, for a total transaction of C$86,500.00. Company insiders own 14.00% of the company’s stock.

Microbix Biosystems Company Profile

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.